Wes Rountree

2.8k total citations
38 papers, 907 citations indexed

About

Wes Rountree is a scholar working on Virology, Epidemiology and Immunology. According to data from OpenAlex, Wes Rountree has authored 38 papers receiving a total of 907 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Virology, 12 papers in Epidemiology and 12 papers in Immunology. Recurrent topics in Wes Rountree's work include HIV Research and Treatment (14 papers), Influenza Virus Research Studies (6 papers) and HIV/AIDS Research and Interventions (6 papers). Wes Rountree is often cited by papers focused on HIV Research and Treatment (14 papers), Influenza Virus Research Studies (6 papers) and HIV/AIDS Research and Interventions (6 papers). Wes Rountree collaborates with scholars based in United States, Italy and Netherlands. Wes Rountree's co-authors include Kavita Nanda, Paul J. Feldblum, R A Bakare, Lily Wang, Anja Lendvay, Adesina Adeiga, Silver Wevill, Leigh Peterson, Rosalie Dominik and Baafuor Kofi Opoku and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and PEDIATRICS.

In The Last Decade

Wes Rountree

35 papers receiving 878 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wes Rountree United States 14 424 303 287 262 201 38 907
Vrasha Chohan United States 15 508 1.2× 420 1.4× 224 0.8× 265 1.0× 136 0.7× 22 899
Melissa Robbiani United States 24 546 1.3× 724 2.4× 484 1.7× 456 1.7× 429 2.1× 54 1.5k
Meropi Aravantinou United States 15 309 0.7× 391 1.3× 260 0.9× 197 0.8× 169 0.8× 26 717
Kamnoosh Shahabi Canada 15 295 0.7× 342 1.1× 443 1.5× 389 1.5× 297 1.5× 24 1.1k
Krista L. Dong United States 14 543 1.3× 562 1.9× 491 1.7× 460 1.8× 370 1.8× 44 1.3k
James E. Cummins United States 14 333 0.8× 468 1.5× 331 1.2× 229 0.9× 202 1.0× 22 805
Johan Míchiels Belgium 17 442 1.0× 219 0.7× 188 0.7× 142 0.5× 130 0.6× 38 824
Sandra Emery United States 16 512 1.2× 489 1.6× 167 0.6× 273 1.0× 119 0.6× 21 893
Brittany A. Bowman United States 7 152 0.4× 163 0.5× 455 1.6× 319 1.2× 273 1.4× 9 821
Nina Derby United States 15 296 0.7× 412 1.4× 172 0.6× 169 0.6× 221 1.1× 27 667

Countries citing papers authored by Wes Rountree

Since Specialization
Citations

This map shows the geographic impact of Wes Rountree's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wes Rountree with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wes Rountree more than expected).

Fields of papers citing papers by Wes Rountree

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wes Rountree. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wes Rountree. The network helps show where Wes Rountree may publish in the future.

Co-authorship network of co-authors of Wes Rountree

This figure shows the co-authorship network connecting the top 25 collaborators of Wes Rountree. A scholar is included among the top collaborators of Wes Rountree based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wes Rountree. Wes Rountree is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Greenberg, Rachel G., Wes Rountree, Mary Allen Staat, et al.. (2025). Apnea After 2-Month Vaccinations in Hospitalized Preterm Infants. JAMA Pediatrics. 179(3). 246–246.
2.
Walter, Emmanuel B., Elizabeth P. Schlaudecker, Kawsar R. Talaat, et al.. (2025). Immunogenicity of mRNA COVID-19 vaccine with either simultaneous or sequentially administered inactivated influenza vaccines: a randomized clinical trial. Vaccine. 72. 128072–128072.
3.
Walter, Emmanuel B., Elizabeth P. Schlaudecker, Kawsar R. Talaat, et al.. (2024). Safety of Simultaneous vs Sequential mRNA COVID-19 and Inactivated Influenza Vaccines. JAMA Network Open. 7(11). e2443166–e2443166. 6 indexed citations
4.
Kraft, Bryan, Simon Verhulst, Tsung‐Po Lai, et al.. (2024). T-cell count and T-cell telomere length in patients with severe COVID-19. Frontiers in Immunology. 15. 1356638–1356638. 3 indexed citations
5.
Hamele, Cait E., Zhaochen Luo, R. Leonard, et al.. (2024). Headless hemagglutinin-containing influenza viral particles direct immune responses toward more conserved epitopes. Journal of Virology. 98(10). e0116624–e0116624. 2 indexed citations
6.
Schmader, Kenneth E., Christine K. Liu, Brendan Flannery, et al.. (2023). Immunogenicity of adjuvanted versus high-dose inactivated influenza vaccines in older adults: a randomized clinical trial. Immunity & Ageing. 20(1). 30–30. 4 indexed citations
7.
Hossain, Md. Alamgir, Kara Anasti, Brian Watts, et al.. (2022). B cells expressing IgM B cell receptors of HIV-1 neutralizing antibodies discriminate antigen affinities by sensing binding association rates. Cell Reports. 39(13). 111021–111021. 3 indexed citations
8.
Blasi, Maria, Erich J. Baker, Celia C. LaBranche, et al.. (2020). Therapeutic vaccination with IDLV-SIV-Gag results in durable viremia control in chronically SHIV-infected macaques. npj Vaccines. 5(1). 36–36. 14 indexed citations
9.
Blasi, Maria, Min-Nung Huang, Anne F. Buckley, et al.. (2020). Skeletal Muscle Is an Antigen Reservoir in Integrase-Defective Lentiviral Vector-Induced Long-Term Immunity. Molecular Therapy — Methods & Clinical Development. 17. 532–544. 18 indexed citations
10.
Blasi, Maria, Donatella Negri, Kevin O. Saunders, et al.. (2020). Immunogenicity, safety, and efficacy of sequential immunizations with an SIV-based IDLV expressing CH505 Envs. npj Vaccines. 5(1). 107–107. 11 indexed citations
11.
Keating, Sheila M., Wes Rountree, Eduard Grebe, et al.. (2019). Development of an international external quality assurance program for HIV-1 incidence using the Limiting Antigen Avidity assay. PLoS ONE. 14(9). e0222290–e0222290. 8 indexed citations
12.
Rountree, Wes, Mark Berrong, Ana M. Sánchez, Thomas N. Denny, & Guido Ferrari. (2016). Variability of the IFN-γ ELISpot assay in the context of proficiency testing and bridging studies. Journal of Immunological Methods. 433. 69–76. 5 indexed citations
13.
Rountree, Wes, Bhavna Hora, Yue Chen, et al.. (2015). HIV-1 subtype C is significantly more infectious than other subtypes. Journal of the International AIDS Society. 18. 1 indexed citations
14.
Bainbridge, John, Cynthia L. Wilkening, Wes Rountree, et al.. (2014). The Immunology Quality Assessment Proficiency Testing Program for CD3+4+ and CD3+8+ lymphocyte subsets: A ten year review via longitudinal mixed effects modeling. Journal of Immunological Methods. 409. 82–90. 9 indexed citations
15.
Staats, Janet, Ana M. Sánchez, Wes Rountree, et al.. (2014). Toward development of a comprehensive external quality assurance program for polyfunctional intracellular cytokine staining assays. Journal of Immunological Methods. 409. 44–53. 12 indexed citations
16.
Sambor, Anna, Mark Berrong, Joy Pickeral, et al.. (2014). Establishment and maintenance of a PBMC repository for functional cellular studies in support of clinical vaccine trials. Journal of Immunological Methods. 409. 107–116. 25 indexed citations
17.
Schwartz, Jill L., Wes Rountree, Angela D. M. Kashuba, et al.. (2011). A Multi-Compartment, Single and Multiple Dose Pharmacokinetic Study of the Vaginal Candidate Microbicide 1% Tenofovir Gel. PLoS ONE. 6(10). e25974–e25974. 88 indexed citations
18.
Halpern, Vera, et al.. (2008). The effects of spermicides containing nonoxynol-9 on cervical cytology. Contraception. 77(3). 191–194. 8 indexed citations
19.
Peterson, Leigh, Kavita Nanda, Baafuor Kofi Opoku, et al.. (2007). SAVVY® (C31G) Gel for Prevention of HIV infection in Women: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial in Ghana. PLoS ONE. 2(12). e1312–e1312. 156 indexed citations
20.
Mauck, Christine, Mitchell D. Creinin, Wes Rountree, Marianne M. Callahan, & Sharon L. Hillier. (2005). Lea's Shield®: colposcopic and microbiological testing during 8 weeks of use. Contraception. 72(1). 53–59. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vrasha Chohan Breakdown of academic impact, for papers by Melissa Robbiani Breakdown of academic impact, for papers by Meropi Aravantinou Breakdown of academic impact, for papers by Kamnoosh Shahabi Breakdown of academic impact, for papers by Krista L. Dong Breakdown of academic impact, for papers by James E. Cummins Breakdown of academic impact, for papers by Johan Míchiels Breakdown of academic impact, for papers by Sandra Emery Breakdown of academic impact, for papers by Brittany A. Bowman Breakdown of academic impact, for papers by Nina Derby
Rankless by CCL
2026